HC Wainwright & Co. Initiates Coverage On Genelux With Buy Rating, Announces Price Target of $35
HC Wainwright & Co. Initiates Coverage On Genelux With Buy Rating, Announces Price Target of $35
HC Wainwright & Co.以買入評級啓動對Genelux的報道，宣佈目標股價爲35美元
HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Genelux (NASDAQ:GNLX) with a Buy rating and announces Price Target of $35.
HC Wainwright & Co. 分析師艾米麗·博德納爾以買入評級開始對Genelux（納斯達克股票代碼：GNLX）進行報道，並宣佈目標股價爲35美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。